Fig. 1 · Structure
Documents & Downloads
Gatuzosiran
Cat. No.
A69055
CAS
2409783-34-0
HSD17B13 synthesis reducer
Gatuzosiran is a small interfering RNA (siRNA) that targets and reduces the synthesis of 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13). This compound plays a crucial role in research focused on fatty liver disease, providing insights into the molecular mechanisms underlying lipid metabolism and liver function. Its ability to modulate HSD17B13 expression makes it a valuable tool for studying the pathophysiology of liver diseases.
Select a Size
Selected package
Cat. No.
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2409783-34-0 |
| Applications | HSD17B13 synthesis reducer |
| Formula | C493H653F11N163O311P43S7 |
| Molecular Weight | 15603.70 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.